NCT01575587View on ClinicalTrials.gov

A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Pharmacology

Interventions

DRUG

Abiraterone: Treatment A

1000 mg abiraterone acetate administered in the fasting state

DRUG

Abiraterone: Treatment B

Standardized meal administered 1 hour after the 1000 mg abiraterone acetate dose

DRUG

Abiraterone: Treatment C

Standardized meal administered 2 hours before the 1000 mg abiraterone acetate dose

DRUG

Abiraterone: Treatment D

Standardized meal administered 2 hours before and 2 hours after the 1000 mg abiraterone acetate dose

Trial Locations (1)

Unknown

Cypress

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT01575587 - A Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Men | Biotech Hunter | Biotech Hunter